Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 Breakthrough Infections in Fully Vaccinated Individuals

Esteban Ramirez, Rebecca P. Wilkes, Giovanna Carpi, Jack Dorman, Craig Bowen, Lisa Smith
doi: https://doi.org/10.1101/2021.06.21.21258990
Esteban Ramirez
1Indiana University School of Medicine, One To One Health, West Lafayette, IN 47906, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Esteban.Ramirez@121.health
Rebecca P. Wilkes
2Purdue University, Animal Disease Diagnostic Laboratory, West Lafayette, IN 47907, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanna Carpi
3Department of Biological Sciences, Purdue University, IN 47907, USA
4Purdue Institute of Inflammation, Immunology and Infectious Disease, West Lafayette, IN 47907, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jack Dorman
3Department of Biological Sciences, Purdue University, IN 47907, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig Bowen
2Purdue University, Animal Disease Diagnostic Laboratory, West Lafayette, IN 47907, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Smith
5University of Tennessee College of Medicine-Chattanooga, One to One Health, Chattanooga, TN 37402, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance While COVID-19 vaccines are highly effective against disease, breakthrough infections may occur in the context of rising variants of concern.

Objective We paired random and passive surveillance nucleic acid testing with analysis of viral whole genomic sequences to detect and describe breakthrough infections, focusing in a university community.

Design Anterior nasal swabs were collected from individuals for a nucleic acid amplification test (NAAT) for detection of SARS-CoV-2. A subset of NAAT positive samples was sequenced to determine variants associated with infections. Included in the testing and sequencing protocol were individuals that were fully vaccinated.

Setting This study was performed as part of a surveillance program for SARS-CoV-2 on a university campus with 49,700 students and employees.

Participants Surveillance testing was random and included approximately 10% of the population each week. Additionally, individuals self-identified with COVID-19 related symptoms or those that had close contact with SARS-CoV-2 positive individuals were also tested.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was in part funded by support to G.C. from the Purdue Department of Biological Sciences.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Data were obtained in deidentified format from the electronic health record system from One-to-One Health. Approval from the One-to-One Health review board was obtained. The Institutional Review Board from the Purdue University Human Research Protection Program determined that viral genome sequencing of deidentified remnant RNA samples included in this study is not research involving human subjects (IRB-2021-438)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Genomic data are available on GISAID (see Table 1 for accession numbers).

https://www.gisaid.org

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 25, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 Breakthrough Infections in Fully Vaccinated Individuals
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 Breakthrough Infections in Fully Vaccinated Individuals
Esteban Ramirez, Rebecca P. Wilkes, Giovanna Carpi, Jack Dorman, Craig Bowen, Lisa Smith
medRxiv 2021.06.21.21258990; doi: https://doi.org/10.1101/2021.06.21.21258990
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 Breakthrough Infections in Fully Vaccinated Individuals
Esteban Ramirez, Rebecca P. Wilkes, Giovanna Carpi, Jack Dorman, Craig Bowen, Lisa Smith
medRxiv 2021.06.21.21258990; doi: https://doi.org/10.1101/2021.06.21.21258990

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (519)
  • Anesthesia (124)
  • Cardiovascular Medicine (1407)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (580)
  • Epidemiology (10264)
  • Forensic Medicine (6)
  • Gastroenterology (526)
  • Genetic and Genomic Medicine (2611)
  • Geriatric Medicine (253)
  • Health Economics (495)
  • Health Informatics (1727)
  • Health Policy (788)
  • Health Systems and Quality Improvement (669)
  • Hematology (266)
  • HIV/AIDS (563)
  • Infectious Diseases (except HIV/AIDS) (12066)
  • Intensive Care and Critical Care Medicine (647)
  • Medical Education (272)
  • Medical Ethics (83)
  • Nephrology (286)
  • Neurology (2448)
  • Nursing (143)
  • Nutrition (374)
  • Obstetrics and Gynecology (486)
  • Occupational and Environmental Health (565)
  • Oncology (1314)
  • Ophthalmology (397)
  • Orthopedics (145)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (341)
  • Pediatrics (776)
  • Pharmacology and Therapeutics (328)
  • Primary Care Research (294)
  • Psychiatry and Clinical Psychology (2390)
  • Public and Global Health (4987)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (520)
  • Respiratory Medicine (680)
  • Rheumatology (307)
  • Sexual and Reproductive Health (253)
  • Sports Medicine (244)
  • Surgery (296)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)